Company’s 36-month beta value is 0.96.Analysts have differing opinions on the stock, with 9 analysts rating it as a “buy,” 4 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for RGEN is 52.10M, and currently, short sellers hold a 6.57% ratio of that floaft. The average trading volume of RGEN on November 28, 2024 was 707.07K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
RGEN) stock’s latest price update
The stock of Repligen Corp (NASDAQ: RGEN) has increased by 2.21 when compared to last closing price of 146.74.Despite this, the company has seen a gain of 7.98% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-12 that Repligen Corporation (NASDAQ:RGEN ) Q3 2024 Results Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Sondra Newman – Vice President, Global Head of Investor Relations Olivier Loeillot – President and Chief Executive Officer Jason Garland – Chief Financial Officer Conference Call Participants Dan Leonard – UBS Dan Arias – Stifel Rachel Vatnsdal – J.P. Morgan Puneet Souda – Leerink Partners Matt Larew – William Blair & Company Jacob Johnson – Stephens Inc. Conor McNamara – RBC Capital Markets Evan Stock – Wells Fargo Matthew Hewitt – Craig-Hallum Subbu Nambi – Guggenheim Securities Justin Bowers – Deutsche Bank Paul Knight – KeyBanc Capital Matt Stanton – Jefferies LLC Operator Good day, ladies and gentlemen, and welcome to Repligen Corporation’s Third Quarter of 2024 Earnings Conference Call.
RGEN’s Market Performance
Repligen Corp (RGEN) has seen a 7.98% rise in stock performance for the week, with a 11.21% gain in the past month and a -0.50% plunge in the past quarter. The volatility ratio for the week is 3.36%, and the volatility levels for the past 30 days are at 4.95% for RGEN. The simple moving average for the past 20 days is 6.66% for RGEN’s stock, with a -3.15% simple moving average for the past 200 days.
Analysts’ Opinion of RGEN
Wells Fargo, on the other hand, stated in their research note that they expect to see RGEN reach a price target of $180. The rating they have provided for RGEN stocks is “Overweight” according to the report published on August 28th, 2024.
Deutsche Bank gave a rating of “Buy” to RGEN, setting the target price at $155 in the report published on June 26th of the current year.
RGEN Trading at 6.56% from the 50-Day Moving Average
After a stumble in the market that brought RGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.96% of loss for the given period.
Volatility was left at 4.95%, however, over the last 30 days, the volatility rate increased by 3.36%, as shares surge +9.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.60% upper at present.
During the last 5 trading sessions, RGEN rose by +7.98%, which changed the moving average for the period of 200-days by -24.42% in comparison to the 20-day moving average, which settled at $140.63. In addition, Repligen Corp saw -16.58% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RGEN starting from Hunt Anthony, who sale 24,246 shares at the price of $139.67 back on Nov 21 ’24. After this action, Hunt Anthony now owns 139,840 shares of Repligen Corp, valued at $3,386,439 using the latest closing price.
Anthony Hunt, the Executive Chairman of Repligen Corp, proposed sale 24,246 shares at $139.66 during a trade that took place back on Nov 21 ’24, which means that Anthony Hunt is holding shares at $3,386,311 based on the most recent closing price.
Stock Fundamentals for RGEN
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.47 for the gross margin
The net margin for Repligen Corp stands at -0.03. The total capital return value is set at -0.0. Equity return is now at value -0.41, with -0.30 for asset returns.
Based on Repligen Corp (RGEN), the company’s capital structure generated 0.21 points at debt to capital in total, while cash flow to debt ratio is standing at 0.32. The debt to equity ratio resting at 0.26. The interest coverage ratio of the stock is -0.29.
Currently, EBITDA for the company is 127.77 million with net debt to EBITDA at -1.28. When we switch over and look at the enterprise to sales, we see a ratio of 13.46. The receivables turnover for the company is 4.77for trailing twelve months and the total asset turnover is 0.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.44.
Conclusion
In a nutshell, Repligen Corp (RGEN) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
